203
Views
0
CrossRef citations to date
0
Altmetric
Articles

Serum brain-derived neurotrophic factor and glial cell-derived neurotrophic factor in patients with first-episode depression at different ages

, , , , , , , , & show all
Pages 118-126 | Received 16 Dec 2021, Accepted 16 Jul 2022, Published online: 18 Aug 2022

References

  • Airaksinen, M. S., & Saarma, M. (2002). The GDNF family: signalling, biological functions and therapeutic value. Nature Reviews. Neuroscience, 3(5), 383–394. https://doi.org/10.1038/nrn812
  • American Psychiatric Association (APA) (2017). What is depression? https://www.psychiatry.org/patients-families/depression/what-is-depression
  • Arancio, O., & Chao, M. V. (2007). Neurotrophins, synaptic plasticity and dementia. Current Opinion in Neurobiology, 17(3), 325–330. https://doi.org/10.1016/j.conb.2007.03.013
  • Bilgiç, A., Çelikkol Sadıç, Ç., Kılınç, İ., & Akça, Ö. F. (2020). Exploring the association between depression, suicidality and serum neurotrophin levels in adolescents. International Journal of Psychiatry in Clinical Practice, 24(2), 143–150. https://doi.org/10.1080/13651501.2020.1723643
  • Bocchio-Chiavetto, L., Bagnardi, V., Zanardini, R., Molteni, R., Nielsen, M. G., Placentino, A., Giovannini, C., Rillosi, L., Ventriglia, M., Riva, M. A., & Gennarelli, M. (2010). Serum and plasma BDNF levels in major depression: a replication study and meta-analyses. The world Journal of Biological Psychiatry: The Official Journal of the World Federation of Societies of Biological Psychiatry, 11(6), 763–773. https://doi.org/10.3109/15622971003611319
  • Brown, E. C., Clark, D. L., Hassel, S., MacQueen, G., & Ramasubbu, R. (2019). Intrinsic thalamocortical connectivity varies in the age of onset subtypes in major depressive disorder. Neuropsychiatric Disease and Treatment, 15, 75–82. https://doi.org/10.2147/NDT.S184425
  • Bukh, J. D., Bock, C., Vinberg, M., Gether, U., & Kessing, L. V. (2011). Differences between early and late onset adult depression. Clinical Practice and Epidemiology in Mental Health : CP & EMH, 7, 140–147. https://doi.org/10.2174/1745017901107010140
  • Bus, B. A., Molendijk, M. L., Tendolkar, I., Penninx, B. W., Prickaerts, J., Elzinga, B. M., & Voshaar, R. C. (2015). Chronic depression is associated with a pronounced decrease in serum brain-derived neurotrophic factor over time. Molecular Psychiatry, 20(5), 602–608. https://doi.org/10.1038/mp.2014.83
  • Caldieraro, M. A., Vares, E. A., Souza, L. H., Spanemberg, L., Guerra, T. A., Wollenhaupt-Aguiar, B., Ferrari, P., Nierenberg, A. A., & Fleck, M. P. (2017). Illness severity and biomarkers in depression: Using a unidimensional rating scale to examine BDNF. Comprehensive Psychiatry, 75, 46–52. https://doi.org/10.1016/j.comppsych.2017.02.014
  • Chen, L., Li, X. S., Zheng, G. E., Xie, G. J., & Cheng, Y. (2020). Peripheral blood BDNF-TrkB signaling in first-episode, drug-free patients with major depressive disorder and schizophrenia. Neuroscience Letters, 714, 134618. https://doi.org/10.1016/j.neulet.2019.134618
  • Cheon, Y. H., Lee, S. G., Kim, M., Kim, H. O., Sun Suh, Y., Park, K. S., Kim, R. B., Yang, H. S., Kim, J. M., Son, C. N., Kyoung Park, E., Kim, S. H., & Lee, S. I. (2018). The association of disease activity, pro-inflammatory cytokines, and neurotrophic factors with depression in patients with rheumatoid arthritis. Brain, Behavior, and Immunity, 73, 274–281. https://doi.org/10.1016/j.bbi.2018.05.012
  • Diniz, B. S., Teixeira, A. L., Miranda, A. S., Talib, L. L., Gattaz, W. F., & Forlenza, O. V. (2012). Circulating Glial-derived neurotrophic factor is reduced in late-life depression. Journal of Psychiatric Research, 46(1), 135–139. https://doi.org/10.1016/j.jpsychires.2011.09.007
  • Ducray, A., Krebs, S. H., Schaller, B., Seiler, R. W., Meyer, M., & Widmer, H. R. (2006). GDNF family ligands display distinct action profiles on cultured GABAergic and serotonergic neurons of rat ventral mesencephalon. Brain Research, 1069(1), 104–112. https://doi.org/10.1016/j.brainres.2005.11.056
  • Dunham, J. S., Deakin, J. F., Miyajima, F., Payton, A., & Toro, C. T. (2009). Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains. Journal of Psychiatric Research, 43(14), 1175–1184. https://doi.org/10.1016/j.jpsychires.2009.03.008
  • Emon, M., Das, R., Nishuty, N. L., Shalahuddin Qusar, M., Bhuiyan, M. A., & Islam, M. R. (2020). Reduced serum BDNF levels are associated with the increased risk for developing MDD: a case-control study with or without antidepressant therapy. BMC Research Notes, 13(1), 83. https://doi.org/10.1186/s13104-020-04952-3
  • Eraydin, I. E., Mueller, C., Corbett, A., Ballard, C., Brooker, H., Wesnes, K., Aarsland, D., & Huntley, J. (2019). Investigating the relationship between age of onset of depressive disorder and cognitive function. International Journal of Geriatric Psychiatry, 34(1), 38–46. https://doi.org/10.1002/gps.4979
  • Fornaro, M., Escelsior, A., Rocchi, G., Conio, B., Magioncalda, P., Marozzi, V., Presta, A., Sterlini, B., Contini, P., Amore, M., Fornaro, P., & Martino, M. (2015). BDNF plasma levels variations in major depressed patients receiving duloxetine. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 36(5), 729–734. https://doi.org/10.1007/s10072-014-2027-7
  • Gollan, J., Raffety, B., Gortner, E., & Dobson, K. (2005). Course profiles of early- and adult-onset depression. Journal of Affective Disorders, 86(1), 81–86. https://doi.org/10.1016/j.jad.2004.12.009
  • Gonul, A. S., Akdeniz, F., Taneli, F., Donat, O., Eker, C., & Vahip, S. (2005). Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. European Archives of Psychiatry and Clinical Neuroscience, 255(6), 381–386. https://doi.org/10.1007/s00406-005-0578-6
  • Greenberg, M. E., Xu, B., Lu, B., & Hempstead, B. L. (2009). New insights in the biology of BDNF synthesis and release: Implications in CNS function. The Journal of Neuroscience : The Official Journal of the Society for Neuroscience, 29(41), 12764–12767. https://doi.org/10.1523/JNEUROSCI.3566-09.2009
  • Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry, 23(1), 56–62. https://doi.org/10.1136/jnnp.23.1.56
  • Hamilton, M. (1959). The assessment of anxiety states by rating. The British Journal of Medical Psychology, 32(1), 50–55. https://doi.org/10.1111/j.2044-8341.1959.tb00467.x
  • Jaumotte, J. D., & Zigmond, M. J. (2014). Comparison of GDF5 and GDNF as neuroprotective factors for postnatal dopamine neurons in ventral mesencephalic cultures. Journal of Neuroscience Research, 92(11), 1425–1433. https://doi.org/10.1002/jnr.23425
  • Jehn, C. F., Becker, B., Flath, B., Nogai, H., Vuong, L., Schmid, P., & Lüftner, D. (2015). Neurocognitive function, brain-derived neurotrophic factor (BDNF) and IL-6 levels in cancer patients with depression. Journal of Neuroimmunology, 287, 88–92. https://doi.org/10.1016/j.jneuroim.2015.08.012
  • Jevtović, S., Karlović, D., Mihaljević-Peleš, A., Šerić, V., Vrkić, N., & Jakšić, N. (2011). Serum Brain-derived neurotrophic factor (BDNF): The severity and symptomatic dimensions of depression. Psychiatria Danubina, 23(4), 363–369.
  • Karege, F., Perret, G., Bondolfi, G., Schwald, M., Bertschy, G., & Aubry, J. M. (2002). Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Research, 109(2), 143–148. https://doi.org/10.1016/S0165-1781(02)00005-7
  • Lee, B. H., Hong, J. P., Hwang, J. A., Na, K. S., Kim, W. J., Trigo, J., & Kim, Y. K. (2016). Plasma glial cell line-derived neurotrophic factor in patients with major depressive disorder: A preliminary study. Acta neuropsychiatrica, 28(1), 45–50. https://doi.org/10.1017/neu.2015.42
  • Lin, P. Y., & Tseng, P. T. (2015). Decreased glial cell line-derived neurotrophic factor levels in patients with depression: A meta-analytic study. Journal of Psychiatric Research, 63, 20–27. https://doi.org/10.1016/j.jpsychires.2015.02.004
  • Lopez, J. P., Kos, A., & Turecki, G. (2018). Major depression and its treatment: MicroRNAs as peripheral biomarkers of diagnosis and treatment response. Current Opinion in Psychiatry, 31(1), 7–16. https://doi.org/10.1097/YCO.0000000000000379
  • Lu, Y., Christian, K., & Lu, B. (2008). BDNF: A key regulator for protein synthesis-dependent LTP and long-term memory? Neurobiology of Learning and Memory, 89(3), 312–323. https://doi.org/10.1016/j.nlm.2007.08.018
  • Matrisciano, F., Bonaccorso, S., Ricciardi, A., Scaccianoce, S., Panaccione, I., Wang, L., Ruberto, A., Tatarelli, R., Nicoletti, F., Girardi, P., & Shelton, R. C. (2009). Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine. Journal of Psychiatric Research, 43(3), 247–254. https://doi.org/10.1016/j.jpsychires.2008.03.014
  • Molendijk, M. L., Bus, B. A., Spinhoven, P., Penninx, B. W., Kenis, G., Prickaerts, J., Voshaar, R. C., & Elzinga, B. M. (2011). Serum levels of brain-derived neurotrophic factor in major depressive disorder: State-trait issues, clinical features and pharmacological treatment. Molecular Psychiatry, 16(11), 1088–1095. https://doi.org/10.1038/mp.2010.98
  • Molendijk, M. L., Spinhoven, P., Polak, M., Bus, B. A., Penninx, B. W., & Elzinga, B. M. (2014). Serum BDNF concentrations as peripheral manifestations of depression: Evidence from a systematic review and meta-analyses on 179 associations (N = 9484). Molecular Psychiatry, 19(7), 791–800. https://doi.org/10.1038/mp.2013.105
  • Nishuty, N. L., Khandoker, M., Karmoker, J. R., Ferdous, S., Shahriar, M., Qusar, M., Islam, M. S., Kadir, M. F., & Islam, M. R. (2019). Evaluation of serum interleukin-6 and C-reactive protein levels in drug-naïve major depressive disorder patients. Cureus, 11(1), e3868. https://doi.org/10.7759/cureus.3868
  • Nomoto, H., Baba, H., Satomura, E., Maeshima, H., Takebayashi, N., Namekawa, Y., Suzuki, T., & Arai, H. (2015). Serum brain-derived neurotrophic factor levels and personality traits in patients with major depression. BMC psychiatry, 15, 33. https://doi.org/10.1186/s12888-015-0413-1
  • Pallavi, P., Sagar, R., Mehta, M., Sharma, S., Subramanium, A., Shamshi, F., Sengupta, U., Qadri, R., Pandey, R. M., & Mukhopadhyay, A. K. (2013). Serum neurotrophic factors in adolescent depression: Gender difference and correlation with clinical severity. Journal of Affective Disorders, 150(2), 415–423. https://doi.org/10.1016/j.jad.2013.04.033
  • Panksepp, J., Moskal, J. R., Panksepp, J. B., & Kroes, R. A. (2002). Comparative approaches in evolutionary psychology: Molecular neuroscience meets the mind. Neuro Endocrinology Letters, 23 Suppl 4, 105–115.
  • Park, S. C., Hahn, S. W., Hwang, T. Y., Kim, J. M., Jun, T. Y., Lee, M. S., Kim, J. B., Yim, H. W., & Park, Y. C. (2014). Does age at onset of first major depressive episode indicate the subtype of major depressive disorder?: The clinical research center for depression study. Yonsei Medical Journal, 55(6), 1712–1720. https://doi.org/10.3349/ymj.2014.55.6.1712
  • Polyakova, M., Schlögl, H., Sacher, J., Schmidt-Kassow, M., Kaiser, J., Stumvoll, M., Kratzsch, J., & Schroeter, M. L. (2017). Stability of BDNF in human samples stored up to 6 months and correlations of serum and EDTA-plasma concentrations. International Journal of Molecular Sciences, 18(6), 1189. https://doi.org/10.3390/ijms18061189
  • Radka, S. F., Hoist, P. A., Fritsche, M., & Altar, C. A. (1996). Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay. Brain Research, 709(1), 122–301. https://doi.org/10.1016/0006-8993(95)01321-0
  • Rao, J. A., Kassel, M. T., Weldon, A. L., Avery, E. T., Briceno, E. M., Mann, M., Cornett, B., Kales, H. C., Zubieta, J. K., Welsh, R. C., Langenecker, S. A., & Weisenbach, S. L. (2015). The double burden of age and major depressive disorder on the cognitive control network. Psychology and Aging, 30(2), 475–485. https://doi.org/10.1037/pag0000027
  • Reichardt, L. F. (2006). Neurotrophin-regulated signalling pathways. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 361(1473), 1545–1564. https://doi.org/10.1098/rstb.2006.1894
  • Riccio, A., Ahn, S., Davenport, C. M., Blendy, J. A., & Ginty, D. D. (1999). Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. Science (New York, N.Y.), 286(5448), 2358–2361. https://doi.org/10.1126/science.286.5448.2358
  • Sagud, M., Nikolac Perkovic, M., Vuksan-Cusa, B., Maravic, A., Svob Strac, D., Mihaljevic Peles, A., Zivkovic, M., Kusevic, Z., & Pivac, N. (2016). A prospective, longitudinal study of platelet serotonin and plasma brain-derived neurotrophic factor concentrations in major depression: effects of vortioxetine treatment. Psychopharmacology, 233(17), 3259–3267. https://doi.org/10.1007/s00213-016-4364-0
  • Shi, Y., Luan, D., Song, R., & Zhang, Z. (2020). Value of peripheral neurotrophin levels for the diagnosis of depression and response to treatment: A systematic review and meta-analysis. European Neuropsychopharmacology : The Journal of the European College of Neuropsychopharmacology, 41, 40–51. https://doi.org/10.1016/j.euroneuro.2020.09.633
  • Skibinska, M., Groszewska, A., Kapelski, P., Rajewska-Rager, A., Pawlak, J., Dmitrzak-Weglarz, M., Szczepankiewicz, A., & Twarowska-Hauser, J. (2018). Val66Met functional polymorphism and serum protein level of brain-derived neurotrophic factor (BDNF) in acute episode of schizophrenia and depression. Pharmacological Reports : PR, 70(1), 55–59. https://doi.org/10.1016/j.pharep.2017.08.002
  • Sun, J., Kong, L., Wu, F., Wei, Y., Zhu, Y., Yin, Z., Deng, X., Jiang, X., Tang, Y., & Wang, F. (2019). Decreased plasma glial cell line-derived neurotrophic factor level in major depressive disorder is associated with age and clinical severity. Journal of Affective Disorders, 245, 602–607. https://doi.org/10.1016/j.jad.2018.11.068
  • Sun, Q., Cui, C., Fu, Y., Ma, S., & Li, H. (2017). Nursing interventions in depressed children with low serum levels of BDNF. Experimental and Therapeutic Medicine, 14(4), 2947–2952. https://doi.org/10.3892/etm.2017.4921
  • Takaku, S., Yanagisawa, H., Watabe, K., Horie, H., Kadoya, T., Sakumi, K., Nakabeppu, Y., Poirier, F., & Sango, K. (2013). GDNF promotes neurite outgrowth and upregulates galectin-1 through the RET/PI3K signaling in cultured adult rat dorsal root ganglion neurons. Neurochemistry International, 62(3), 330–339. https://doi.org/10.1016/j.neuint.2013.01.008
  • Takebayashi, M., Hisaoka, K., Nishida, A., Tsuchioka, M., Miyoshi, I., Kozuru, T., Hikasa, S., Okamoto, Y., Shinno, H., Morinobu, S., & Yamawaki, S. (2006). Decreased levels of whole blood glial cell line-derived neurotrophic factor (GDNF) in remitted patients with mood disorders. The International Journal of Neuropsychopharmacology, 9(5), 607–612. https://doi.org/10.1017/S1461145705006085
  • Wagner, S., Wollschläger, D., Dreimüller, N., Engelmann, J., Herzog, D. P., Roll, S. C., Tadić, A., & Lieb, K. (2020). Effects of age on depressive symptomatology and response to antidepressant treatment in patients with major depressive disorder aged 18 to 65 years. Comprehensive Psychiatry, 99, 152170. https://doi.org/10.1016/j.comppsych.2020.152170
  • Wakeman, D. R., Redmond, D. E., Jr., Dodiya, H. B., Sladek, J. R., Jr., Leranth, C., Teng, Y. D., Samulski, R. J., & Snyder, E. Y. (2014). Human neural stem cells survive long term in the midbrain of dopamine-depleted monkeys after GDNF overexpression and project neurites toward an appropriate target. Stem Cells Translational Medicine, 3(6), 692–701. https://doi.org/10.5966/sctm.2013-0208
  • Wang, X., Hou, Z., Yuan, Y., Hou, G., Liu, Y., Li, H., & Zhang, Z. (2011). Association study between plasma GDNF and cognitive function in late-onset depression. Journal of Affective Disorders, 132(3), 418–421. https://doi.org/10.1016/j.jad.2011.03.043
  • World Health Organization (WHO) (2017). Depression: let’s talk. http://www.who.int/mental_health/management/depression/en/
  • Xiao, L., Zhou, J. J., Feng, Y., Zhu, X. Q., Wu, W. Y., Hu, Y. D., Niu, Y. J., Hu, J., Wang, X. Y., Gao, C. G., Zhang, N., Fang, Y. R., Liu, T. B., Jia, F. J., Feng, L., & Wang, G. (2020). Does early and late life depression differ in residual symptoms, functioning and quality of life among the first-episode major depressive patients. Asian Journal of Psychiatry, 47, 101843. https://doi.org/10.1016/j.ajp.2019.101843

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.